fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Exceptional launch for Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease – Verona Pharma

Written by | 15 Jan 2025

Verona Pharma plc  announces preliminary unaudited net product sales for the fourth quarter and full year ended December 31, 2024, and provides a corporate update. “2024 was another… read more.

Inhaler misuse leads to mismanagement of COPD symptoms, increased exacerbations

Written by | 26 Aug 2024

Inhaler misuse leading to inadequate medication delivery impacts a person’s ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper inhaler use is… read more.

Dupixent (dupilumab) approved in the EU as the first-ever targeted therapy for patients with COPD – Sanofi + Regeneron

Written by | 14 Jul 2024

The European Medicines Agency (EMA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils…. read more.

Gabapentinoid use appears to raise risk of COPD exacerbation

Written by | 16 Jan 2024

Researchers from a large retrospective study report that, among patients diagnosed with COPD (chronic obstructive pulmonary disease), gabapentinoid use appears to be associated with an increase in the… read more.

Suspected bronchiectasis associated with higher risk of mortality in smokers

Written by | 14 Nov 2023

Bronchiectasis, a condition defined by widened lung airways, cough and sputum production, and frequent infections, often presents along with chronic obstructive pulmonary disease (COPD). This overlap is associated… read more.

Patients with COPD have higher mortality in year after surgery

Written by | 19 Jan 2023

Patients diagnosed with chronic obstructive pulmonary disease (COPD) who have major surgery have a higher mortality rate in the year after surgery than similar patients who do not… read more.

Some surprisingly good news about Chronic Obstructive Pulmonary Disease

Written by | 8 Dec 2022

Chronic Obstructive Pulmonary Disease (COPD) — a debilitating chronic lung disease that includes emphysema and chronic bronchitis — has previously been linked to mental health problems, such as… read more.

Bronchodilators don’t improve smoking-related respiratory symptoms in people without COPD

Written by | 15 Sep 2022

Researchers supported by the National Institutes of Health have found that dual bronchodilators — long-lasting inhalers that relax the airways and make it easier to breathe — do… read more.

Stopping lung damage before it turns deadly

Written by | 12 May 2022

If you’ve ever struggled to breathe, you’ve had a moment of hypoxia — a lack of oxygen. Hypoxia can have long-term effects. In fact, doctors describe hypoxia as… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.